Track-and-trace regulations around the world represent a complex and ever-evolving set of requirements based on where you operate and what sort of pharmaceuticals you manufacture, distribute or dispense. Read on to learn more.
Around the world, countries are introducing new legislation aimed at preventing counterfeit and harmful goods from entering the global supply chain. These new rules, necessary to boost public safety and confidence in global markets, show broad adoption of end-to-end traceability, embracing the notion that any single product should be fully traceable from its manufacturer down through distribution channels to retailers, health systems, pharmacies, and other public-facing businesses. However, such rules aren’t always easy to implement or follow. Some of these regulations outline systems, solutions, or methods of collaboration that have not been fully developed, are not immediately accessible to industry, or are difficult to roll out at-scale. Often, businesses struggle to understand their new responsibilities even as they commit staff hours to implementing them, a position that can incur additional costs and hurt productivity – without certainty of protection from regulatory penalties or reputational damage.
通过 LSPedia 探索美洲各地的药品法规。从具有里程碑意义的美国 DSCSA 到例外试点等,我们的综合资源中心可让您随时了解动态制药领域的合规标准。
借助LSPedia的专用资源中心,保持欧洲药品法规的领先地位。从欧盟口蹄疫到食品和烟草法规以及 EMVO SDK,我们的全面内容可确保在充满活力的欧洲市场中保持合规性。
我们很乐意听取你的意见!